US2013224276A1PendingUtilityA1

Compositions and methods for coating medical implants

63
Assignee: ANGIOTECH INT AGPriority: May 24, 2002Filed: Mar 18, 2013Published: Aug 29, 2013
Est. expiryMay 24, 2022(expired)· nominal 20-yr term from priority
A61P 43/00A61L 29/085A61L 2300/416A61L 29/16A61L 27/34A61L 2300/404A61L 27/54A61P 31/00
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Medical implants are provided which release an anthracycline, fluoropyrimidine, folic acid antagonist, podophylotoxin, camptothecin, hydroxyurea, and/or platinum complex, thereby inhibiting or reducing the incidence of infection associated with the implant.

Claims

exact text as granted — not AI-modified
1 - 12 . (canceled) 
     
     
         13 . A composition, comprising a polymer and a fluoropyrimidine, wherein said fluoropyrimidine is present in said composition at a concentration of less than 10 −4  M. 
     
     
         14 . The composition according to  claim 13  wherein said fluoropyrimidine is present in said composition at a concentration of less than any one of 10 −5  M, 10 −6  M, or 10 −7  M. 
     
     
         15 . The composition according to  claim 13  wherein said polymer is a non-biodegradable polymer. 
     
     
         16 . The composition according to  claim 13  wherein said polymer is a polyurethane. 
     
     
         17 . The composition according to  claim 13  wherein said polymer is a poly(lactide-co-glycolide). 
     
     
         18 . The composition according to  claim 13  wherein said fluoropyrimidine is 5-fluorouracil. 
     
     
         19 . A method for reducing or inhibiting infection associated with a medical implant, comprising the step of introducing into a patient a medical implant which has been covered or coated with a fluoropyrimidine. 
     
     
         20 . The method according to  claim 19  wherein said fluoropyrimidine is 5-fluorouracil. 
     
     
         21 . A method for making medical implants, comprising covering or coating a medical implant with a fluoropyrimidine. 
     
     
         22 . The method according to  claim 21  wherein said fluoropyrimidine is 5-fluorouracil. 
     
     
         23 . The method according to  claim 21  wherein said medical implant covered or coated by dipping or by impregnation.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.